XML 265 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock, at Cost
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Stockholders’ Equity
Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interest
Beginning balance (in shares) at Jan. 26, 2020     65,758,115                
Beginning balance at Jan. 26, 2020 $ 677,200 $ (314) $ 785 $ (387,851) $ 458,579 $ 611,607 $ (314) $ (6,166) $ 676,954 $ (314) $ 246
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 59,867         59,903     59,903   (36)
Other comprehensive income (loss) (2,002)             (2,002) (2,002)    
Share-based compensation 48,626       48,626       48,626    
Repurchase of common stock (in shares)     (1,597,104)                
Repurchase of common stock (71,433)     (71,433)         (71,433)    
Treasury stock reissued (in shares)     937,368                
Treasury stock reissued to settle share-based awards (12,991)     20,486 (33,477)       (12,991)    
Ending balance (in shares) at Jan. 31, 2021     65,098,379                
Ending balance at Jan. 31, 2021 698,953   $ 785 (438,798) 473,728 671,196   (8,168) 698,743   210
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 125,645         125,664     125,664   (19)
Other comprehensive income (loss) 6,093             6,093 6,093    
Share-based compensation 50,966       50,966       50,966    
Repurchase of common stock (in shares)     (1,768,772)                
Repurchase of common stock (129,746)     (129,746)         (129,746)    
Treasury stock reissued (in shares)     768,958                
Treasury stock reissued to settle share-based awards $ (14,136)     18,602 (32,738)       (14,136)    
Ending balance (in shares) at Jan. 30, 2022 64,098,565   64,098,565                
Ending balance at Jan. 30, 2022 $ 737,775   $ 785 (549,942) 491,956 796,860   (2,075) 737,584   191
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 61,372         61,380     61,380   (8)
Other comprehensive income (loss) 5,435             5,435 5,435    
Sale of warrants 42,909       42,909       42,909    
Purchase of convertible note hedge (72,559)       (72,559)       (72,559)    
Share-based compensation 44,673       44,673       44,673    
Repurchase of common stock (in shares)     (762,093)                
Repurchase of common stock (50,000)     (50,000)         (50,000)    
Treasury stock reissued (in shares)     534,109                
Treasury stock reissued to settle share-based awards $ (13,570)     22,035 (35,605)       (13,570)    
Ending balance (in shares) at Jan. 29, 2023 63,870,581   63,870,581                
Ending balance at Jan. 29, 2023 $ 756,035   $ 785 $ (577,907) $ 471,374 $ 858,240   $ 3,360 $ 755,852   $ 183